A Vitamin D analog, Ro26-2198, was found to inhibit COX-2 signaling and delay the onset of clinical colitis in an azoxymethane, dextran sulfate sodium mouse model, as well as to inhibit COX-2 induction and decrease proliferation in HCA-7 colon cancer cells. This evidence concerns the gene PTGS2 and malignant colon neoplasm.